Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiretroviral Therapy and Immune Reconstitution in Chinese HIV/AIDS Patients
NCT00872417Phase 4Unknown
- Sponsor
- Peking Union Medical College
- Start
- Mar 2009
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lamivudine, nevirapine, stavudine, zidovudine, tenofovir disoproxil fumarate and 2 more in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) (3 arms), sponsored by Peking Union Medical College. Primary endpoint: Evidence to make first line or second line ARV treatment strategy at 2 years. Status: unknown.
02
Drugs
lamivudinenevirapinestavudinezidovudinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on NCT00872417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872417.